Levothyroxine Titration Protocol
For young healthy adults with overt hypothyroidism, start with full replacement dosing at 1.6 mcg/kg/day and check TSH every 4-8 weeks, adjusting by 12.5-25 mcg increments until TSH normalizes; for patients over 50-60 years, start at 50 mcg daily and titrate more slowly every 6-8 weeks. 1, 2
Initial Dosing Strategy
The starting dose depends critically on three factors: age, cardiac status, and severity of hypothyroidism.
Young Healthy Adults (Overt Hypothyroidism)
- Start with full replacement: 1.6 mcg/kg/day based on ideal body weight 1
- This approach leads to faster TSH normalization without compromising safety 1
- Young patients tolerate aggressive initial dosing well
Older Adults (>50-60 years) Without Cardiac Disease
- Start at 50 mcg daily 1
- Elderly patients require 20-25% less per kilogram due to decreased lean body mass 1
- More conservative approach prevents cardiac complications
Patients With Known Cardiac Disease or At Risk for Atrial Fibrillation
- Start at 12.5-25 mcg daily 1, 2
- Titrate every 6-8 weeks (slower than standard) 2
- Monitor closely for anginal symptoms 1
- Even minor over-replacement risks cardiac events 3
Subclinical Hypothyroidism
- Start at 25-75 mcg daily depending on TSH elevation 1
- One randomized trial used: 25 mcg for TSH 4.0-8.0 mIU/L, 50 mcg for TSH 8-12 mIU/L, 75 mcg for TSH >12 mIU/L 1
- After 2 months, minimal further adjustments were needed 1
TSH Monitoring Schedule
Check TSH 4-8 weeks after initiation or any dose change 1. This timing is critical because:
- Peak therapeutic effect takes 4-6 weeks to manifest 2
- Smaller doses (25-50 mcg) may require 8 weeks or longer before TSH plateaus 1
- Larger doses (50-75 mcg) may show TSH decline within a month 1
Long-term Monitoring
Once TSH stabilizes in normal range:
- Check every 6 months initially, then annually 1
- Some experts recommend more frequent testing to ensure compliance 1
Dose Adjustment Protocol
Adjust in 12.5-25 mcg increments 1, 2
- Even smaller increments may be necessary to achieve goal TSH 1
- Wait 4-8 weeks between adjustments to allow steady state 1
- For cardiac patients, wait 6-8 weeks between adjustments 2
Target TSH Goals
- Primary hypothyroidism: TSH within normal reference range 1
- Secondary/tertiary hypothyroidism: Use free T4 (not TSH) targeting upper half of normal range 1, 2
- Pregnancy: First trimester TSH <2.5 mIU/L, second trimester <3 mIU/L, third trimester <3.5 mIU/L 1
Administration Instructions
Take levothyroxine with water 30-60 minutes before breakfast OR at bedtime 4 hours after the last meal 1. This is critical for absorption:
- Taking 60 minutes before breakfast is superior to 30 minutes 1
- Taking 4 hours after last meal is better than within 2 hours 1
- Consistency matters more than the specific method chosen 1
Common Pitfalls to Avoid
Absorption interference is a major cause of treatment failure:
- Do not take with substances that impair absorption (calcium, iron, proton pump inhibitors, soy products) 1
- If patient requires >200 mcg/day with persistently elevated TSH, suspect non-compliance or malabsorption 1
- Inadequate response to >300 mcg/day is rare and indicates poor compliance, malabsorption, or drug interactions 2
Recheck TSH within 4-8 weeks when starting drugs that affect levothyroxine bioavailability or metabolism 1. This is a Grade A recommendation.
Special Populations
Pregnancy
- Increase weekly dose by 30% immediately upon pregnancy confirmation (take 9 doses per week instead of 7) 4
- Monitor TSH and free T4 every 4 weeks during first half of pregnancy 1
- Check at least once between 26-32 weeks gestation 1
Resuming After Interruption
- If interruption <6 weeks without cardiac event or weight loss: resume full previous dose 1
Central Hypothyroidism
Clinical Nuances
Some hypothyroid symptoms (chronic skin changes) may take 3-6 months to resolve even after TSH normalizes 1. Set appropriate patient expectations.
The evidence does not support targeting specific TSH values within the normal range for non-pregnant patients 1—any value in the normal range is acceptable once the patient is clinically euthyroid.